Press Releases

 
Press Releases
  Date Title View
Dec 6, 2000
Contact: Dino Dina, M.D. President and CEO Dynavax Technologies Corporation (510) 848-5100 or (877) 848-5100 Berkeley, CA, December 6, 2000 - Dynavax Technologies Corporation today announced that it has named three new vice presidents, including Robert Lee Coffman, Ph.D., as Vice Preside...
Apr 25, 2002
Contact: Andrew Gengos Chief Financial Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA, April 25, 2002 - Dynavax Technologies, a privately held biopharmaceutical company, today announced that it had raised $34.8 million in a private placement of its Series D Preferred St...
Aug 22, 2002
Contact: Dynavax Technologies Corporation Dino Dina, M.D. President and CEO 510-848-5100 Berkeley, CA -- August 22, 2002 - Dynavax Technologies Corporation today announced the appointment of William J. Dawson to the position of vice president, finance and operations, and chief financial o...
Sep 4, 2002
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA, September 4, 2002 - Dynavax Technologies, a privately held biopharmaceutical company, today announced it has initiated a Phase II clinical study to evaluate the abilit...
Aug 4, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA - August 4, 2003 - Dynavax Technologies Corporation today announced the appointment of Daniel Levitt, M.D., Ph.D., to the position of vice president and chief medical officer. He...
Oct 24, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA - October 24, 2003 - Dynavax Technologies Corporation announced today that it has filed a registration statement with the Securities and Exchange Commission for the initial public o...
Nov 3, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berna Biotech Ltd BĂ©atrice Keller Communications Manager communications@bernabiotech.com Phone +41 (0) 31 980 6522 Fax +41 (0) 31 980 6229 Ber...
Dec 18, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA - December 18, 2003 - Dynavax Technologies Corporation, a privately held biopharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has de...
Feb 5, 2004
Berkeley, CA - February 5, 2004 - Dynavax Technologies Corporation announced today that it has entered into an agreement with UCB Pharma, the pharmaceuticals division of UCB Group, a publicly traded multi-national company based in Brussels, Belgium, in which Dynavax licensed the technology, know-how and preclinical and clinical data related to i...
Feb 19, 2004
BERKELEY, Calif., Feb. 18 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX) announced today that it has priced its initial public offering of 6,000,000 shares of its common stock at $7.50 per share, below the estimated range. Dynavax Technologies Corporation discovers, develops, and intends to commercial...
1
...
NextLast
= add release to Briefcase